90 Miles From Tyranny : Moderna Announces mRNA Vaccine To Treat ‘Sudden’ Surge in Turbo-Cancers

infinite scrolling

Saturday, February 4, 2023

Moderna Announces mRNA Vaccine To Treat ‘Sudden’ Surge in Turbo-Cancers

Big Pharma giant Moderna has announced plans to launch an mRNA vaccine to treat the sudden surge in turbo-cancers that has occurred following the COVID jab rollout.

During the recent World Economic Forum in Davos, Switzerland, Moderna CEO Stephane Bancel admitted that he would “like to have mRNA capacity on every continent.”

“The mRNA technology rollout is so concerning,” said Tracy Beanz, news and editorial contributor for The HighWire. “They’d never tested this on humans before March of 2020, and now they’re pushing this lipid nanoparticle into the arms of every citizen on the planet.”

“And they’re not looking to stop with just the [Wuhan coronavirus] COVID vaccines,” continued Beanz. “They’re expanding.” She boasted that Moderna is planning to release mRNA-based vaccines for other common health conditions like MERS, SARS, Marburg virus disease and the Zika fever.

Naturalnews.com reports: Moderna is also developing mRNA-based vaccines for respiratory syncytial virus (RSV) and an aggressive type of skin cancer.

The Big Pharma company’s RSV vaccine is already in phase 3 of trial testing, with data released by the company claiming it is 83.7 percent effective at preventing moderate cases of the disease, which is defined as a bout of RSV with two or more symptoms. The company further claimed that the vaccine candidate is 82.4 percent effective at dealing with a severe case of RSV, defined by having three or more symptoms.

Moderna hopes to get the Food and Drug Administration to approve of the company’s RSV vaccine by the end of the year.

The company’s skin cancer mRNA vaccine, which it is developing with Merck, is allegedly showing promise in its phase 2 trial.

Data released by the company claimed that the mRNA vaccine, when used in combination with an immunotherapy drug called Keytruda sold by Merck, reduced the risk of death or recurrence of melanoma in high-risk patients by 44 percent compared with treatment using only Keytruda.

The phase 2 trial enrolled 157 participants. Due to its so-called early successes, Bancel is preparing to move Moderna toward holding larger phase 3 trials. These trials will involve the company testing the vaccine and immunotherapy drug combination with other kinds of cancer, with Bancel claiming that it “should work in...

Read More HERE


RonRobot said...

Do I have this right? They've come up with an injection to stop the cancers caused by their first injection? F'em.

stawayno said...

Only an idiot wold believe anything they tell us anymore, especially if it involves mRNA. Adn they have this solidly test in TWO years? Soory, I'll pass forever.

Anonymous said...

Still...no thanks keep it...shove it.

JG said...

These drugs are made in China, Hospitals and Doctors make money to keep you on a leash never quite healing. I trust none of Big Pharma, Hospitals, and 99% of Doctors as they are tied into large medical plans. I never took the vaccines for COVID as I researched and the virus came from China and so did the vaccines.